AINMF (NetraMark Holdings) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AINMF NetraMark Holdings Inc AINMF
31 GF Score
Price $0.66
GF Value $0.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is NetraMark Holdings FFO per Share?

FFO per Share only applies to REITs.

AINMF
31GF Score
NetraMark Holdings Inc AINMF
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NetraMark Holdings (AINMF) Overvalued in 2026?

Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued. The current stock price of $0.66 is trading 213.4% above its estimated GF Value™ of $0.21. GuruFocus considers NetraMark Holdings to be Significantly Overvalued.

Key valuation signals for AINMF:

  • FFO per Share:
  • GF Value™: $0.21 vs. price of $0.66 (213.4% above fair value)
  • GF Score™: 31/100 with 2 warning signs

No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NetraMark Holdings Business Description

Other Exchanges PF0:GermanyAIAI:Canada
Address 1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
31GF Score

Get the complete analysis for AINMF

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.66
Price
$0.21
GF Value